Skip to content
10-K

Annual Report

Ensysce Biosciences, Inc. ENSC ENSCW

0001493152-26-013633

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 27, 2026 9.28M sh
Shares Diluted FY 2025 · Dec 31, 2025 2.56M sh
Shares Diluted FY 2025 · Dec 31, 2024 697.69K sh
Capex FY 2025 · Dec 31, 2025 $123.64K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$7.81M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$7.5M
Cash And Equivalents FY 2025 · Dec 31, 2025 $4.31M
Cash And Equivalents FY 2025 · Dec 31, 2024 $3.5M
Stockholders Equity FY 2025 · Dec 31, 2025 $3.21M
Stockholders Equity FY 2025 · Dec 31, 2024 $3.71M
Current Liabilities FY 2025 · Dec 31, 2025 $4.57M
Current Liabilities FY 2025 · Dec 31, 2024 $2.21M
Total Liabilities FY 2025 · Dec 31, 2025 $4.57M
Total Liabilities FY 2025 · Dec 31, 2024 $2.22M
Current Assets FY 2025 · Dec 31, 2025 $7.24M
Current Assets FY 2025 · Dec 31, 2024 $5.34M
Total Assets FY 2025 · Dec 31, 2025 $7.45M
Total Assets FY 2025 · Dec 31, 2024 $5.6M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.98
Eps Diluted FY 2025 · Dec 31, 2024 −$11.45
Eps Basic FY 2025 · Dec 31, 2025 −$3.98
Eps Basic FY 2025 · Dec 31, 2024 −$11.45
Rd Expense FY 2025 · Dec 31, 2025 $10.38M
Rd Expense FY 2025 · Dec 31, 2024 $7.22M
Operating Income FY 2025 · Dec 31, 2025 −$10.24M
Operating Income FY 2025 · Dec 31, 2024 −$6.73M
Revenue FY 2025 · Dec 31, 2025 $5.07M
Revenue FY 2025 · Dec 31, 2024 $5.21M